What is LLY's current stock price?

As of now, LLY is trading at $1009.38, with a daily change of +1.62%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY

Eli Lilly and

$1009.38

+$16.09 | +1.62%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$1111.99

MKT CAP

$954.25B

52W Low

$623.78

VOL

$4.49M

P/E Ratio

49.36

AVG VOL

$4.22M

RSI

53.77

TREND

Uptrend

LLY Stock IQ

Login to see Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Target Price

Login to display

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Investors confidence is positive

LLY Rewards

Trading below its fair value

Technical Indicators

LLY Technical Indicators

5+ Days Down

LLY Price Performance

$1024.95 (-1.52%)

$762.93 (+32.30%)

$798.89 (+26.35%)

$794.14 (+27.10%)

1year

6month

3month

1month

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Analysts Opinion

LLY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

65%

94%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

83%

11%

Positive

Negative

59 out of 71
events present

8 out of 71
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$997.59

Resistance
Price

$890.57

Current Price Range

$1109.94

Show methods +

Linked to LLY

IQ

Close Price

Change

NVO

3.91

50.29

+2.49%

PFE

3.94

25.80

+0.08%

SNY

4.02

48.86

+1.24%

NVS

4.27

132.36

+0.90%

MRK

4.03

99.01

+1.42%

LLY Latest Analysis +

Eli Lillys Next-Gen Experimental Drug Cuts Body Weight By 29% Helps In Knee Pain. ) on Thursday shared topline results from the Phase 3 TRIUMPH-4 trial evaluating the two highest investigational doses of retatrutide.Eli Lilly shares are advancing steadily. Retatrutide is a GIP GLP-1 and glucagon triple hormone receptor agonist in adults with and knee osteoarthritis and without diabetes.Each dose of retatrutide (9 mg and 12 mg) met all primary and key secondary endpoints delivering significant w

Today

$1009.38 | +1.62%

Activity

Can Eli Lilly Sustain Its Obesity Momentum as Newer Players Emerge?. LLY leans on tirzepatide and a deep late-stage pipeline to defend its obesity momentum as new rivals make rapid progress in the development of their GLP-1 therapies.

Today

$1009.38 | +1.62%

Activity

Lillys Retatrutide Achieves Significant Weight Loss Eases Osteoarthritis Pain In Phase 3 Trial . (RTTNews) - Eli Lilly and Co. (LLY) announced Thursday positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of the two highest investigational doses of retatrutide a first-in-class GIP GLP-1 and glucagon triple hormone receptor a

Today

$1009.38 | +1.62%

Activity

Eli Lilly stock climbs after retatrutide delivers massive weight loss in trial.

Today

$1009.38 | +1.62%

Momentum

Eli Lillys Mounjaro Added to Chinas National Health Insurance for Diabetes. Eli Lilly and Company (NYSE:LLY) is included among the 15 Best Stocks to Buy for the Long Term. Eli Lilly and Company (NYSE:LLY)s popular drug Mounjaro will be added to Chinas state-run health insurance program starting January 1 the National Healthcare Security Administration said in a notice on December 8. Analysts say that the move [….]

Today

$1009.38 | +1.62%

Activity

Potential

Warning: This Skyrocketing Stock Has a Hidden Risk. Key PointsEli Lilly is currently the leader in the GLP-1 weight loss drug space.

Wed Dec 10, 2025

$993.64 | +1.18%

Momentum

Eli Lilly acquisition rumors reportedly fuel Abivax rally.

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Eli Lillys $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills. .The synthetic medicine active pharmaceutical ingredient (API) facility is the third of four new United States sites Eli Lilly plans to announce will produce small molecule synthetic and peptide medicines.In February Eli Lilly bolstered its domestic medicine production with total United States capital expansion commitments of .Also Read: The company’.s previous total domestic capital expansion commitments from 2020 to 20

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Lilly To Invest $6 Bln In New Huntsville Manufacturing Facility . (RTTNews) - Eli Lilly and Company (LLY) announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville Alabama. This next-generation synthetic medicine active pharmaceutical ingredient (API) site will be the third of four new United States facilities Lilly i

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Eli Lilly to build $6B API manufacturing plant in Alabama.

Tue Dec 9, 2025

$982.22 | -1.53%

Activity

FAQ About LLY Stock Insights

What is LLY current stock price?

What are LLY stock strengths?

What is LLY Risk Level?

What is LLY market cap and volume?

What is LLY current Stock IQ?

Should I buy LLY stock right now?

Is LLY a Strong Buy right now?

What does a 'Strong Buy' rating mean for LLY?

What does a 'Strong Sell' rating mean for LLY?

What factors influence LLY's Stock IQ?

Explore our LLY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LLY Stock Strategies
Effective Risk Management

FIND US ON

Receive our LLY Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LLY

Eli Lilly and

Current Price

$1009.38

+$16.09 | +1.62%

52W High

$1111.99

MKT CAP

$954.25B

52W Low

$623.78

VOL

$4.49M

P/E Ratio

49.36

AVG VOL

$4.22M

RSI

53.77

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Investors confidence is positive

LLY Rewards

Trading below its fair value

Technical Indicators

LLY Technical Indicators

5+ Days Down

Linked to LLY

Symbol

IQ

Close

Change

NVO

3.91

50.29

+2.49%

PFE

3.94

25.80

+0.08%

SNY

4.02

48.86

+1.24%

NVS

4.27

132.36

+0.90%

MRK

4.03

99.01

+1.42%

LLY Price Performance

$1024.95 (-1.52%)

$762.93 (+32.30%)

$798.89 (+26.35%)

$794.14 (+27.10%)

1year

6month

3month

1month

LLY Analysts Opinion

LLY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

65%

94%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

83%

11%

Positive

Negative

59 out of 71
events present

8 out of 71
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$997.59

Resistance
Price

$890.57

Current Price Range

$1109.94

Show methods +

LLY Stock IQ

Login to unlock Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Latest Analysis

Eli Lillys Next-Gen Experimental Drug Cuts Body Weight By 29% Helps In Knee Pain. ) on Thursday shared topline results from the Phase 3 TRIUMPH-4 trial evaluating the two highest investigational doses of retatrutide.Eli Lilly shares are advancing steadily. Retatrutide is a GIP GLP-1 and glucagon triple hormone receptor agonist in adults with and knee osteoarthritis and without diabetes.Each dose of retatrutide (9 mg and 12 mg) met all primary and key secondary endpoints delivering significant w

Today

$1009.38 | +1.62%

Activity

Can Eli Lilly Sustain Its Obesity Momentum as Newer Players Emerge?. LLY leans on tirzepatide and a deep late-stage pipeline to defend its obesity momentum as new rivals make rapid progress in the development of their GLP-1 therapies.

Today

$1009.38 | +1.62%

Activity

Lillys Retatrutide Achieves Significant Weight Loss Eases Osteoarthritis Pain In Phase 3 Trial . (RTTNews) - Eli Lilly and Co. (LLY) announced Thursday positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of the two highest investigational doses of retatrutide a first-in-class GIP GLP-1 and glucagon triple hormone receptor a

Today

$1009.38 | +1.62%

Activity

Eli Lilly stock climbs after retatrutide delivers massive weight loss in trial.

Today

$1009.38 | +1.62%

Momentum

Eli Lillys Mounjaro Added to Chinas National Health Insurance for Diabetes. Eli Lilly and Company (NYSE:LLY) is included among the 15 Best Stocks to Buy for the Long Term. Eli Lilly and Company (NYSE:LLY)s popular drug Mounjaro will be added to Chinas state-run health insurance program starting January 1 the National Healthcare Security Administration said in a notice on December 8. Analysts say that the move [….]

Today

$1009.38 | +1.62%

Activity

Potential

Warning: This Skyrocketing Stock Has a Hidden Risk. Key PointsEli Lilly is currently the leader in the GLP-1 weight loss drug space.

Wed Dec 10, 2025

$993.64 | +1.18%

Momentum

Eli Lilly acquisition rumors reportedly fuel Abivax rally.

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Eli Lillys $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills. .The synthetic medicine active pharmaceutical ingredient (API) facility is the third of four new United States sites Eli Lilly plans to announce will produce small molecule synthetic and peptide medicines.In February Eli Lilly bolstered its domestic medicine production with total United States capital expansion commitments of .Also Read: The company’.s previous total domestic capital expansion commitments from 2020 to 20

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Lilly To Invest $6 Bln In New Huntsville Manufacturing Facility . (RTTNews) - Eli Lilly and Company (LLY) announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville Alabama. This next-generation synthetic medicine active pharmaceutical ingredient (API) site will be the third of four new United States facilities Lilly i

Wed Dec 10, 2025

$993.64 | +1.18%

Activity

Eli Lilly to build $6B API manufacturing plant in Alabama.

Tue Dec 9, 2025

$982.22 | -1.53%

Activity

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LLY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LLY Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LLY Stock trends

LLY Stock performance

LLY Stock analysis

LLY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY Stock IQ

LLY Target Price

LLY Risk Level

LLY Analysts Opinion

LLY Street Sentiment

LLY Performance Sentiment

Technical Price Levels

Explore our LLY Stock insights

Receive our LLY Daily Alerts

LLY Street Sentiment

LLY Risk Level

Technical Price Levels

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LLY. We're here to help you make informed investment decisions today.

Receive our LLY Daily Alerts

LLY Runner Alarm